Mark Agius - Concepedia

Author

Mark Agius

Also Known As

Alexander Nawka, Daniela Petrić, M A Agius, M Agius, M. A. AGIUS, M. A. Agius, M. AGIUS, M. Agius, MARK A. AGIUS, MARK AGIUS

424

Publications

Citations

H-Index

159

Concepts

All Affiliations

University of Cambridge University of California, Davis South Essex Partnership University Foundation NHS Trust Cambridge School University of Chicago

About

Mark Agius is an author at University of Cambridge specializing in medicine, psychiatry, and psychopathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	41	1.9K
2	Education	4	4	151
3	Public Health	3	3	109
4	Arts	1	1	20
5	Nursing	1	1	12

Mark Agius

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial Peter A. Calabresi, Ernst-Wilhelm Radüe, Douglas S. Goodin, The Lancet Neurology Disease ManagementRelapsing-remitting Multiple SclerosisDisease ProgressionNeurological DisorderClinical Trials	2014	815
Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma EUN‐KYU LEE, Ricardo A. Maselli, William G. Ellis, Journal of Neurology Neurosurgery & Psychiatry	1998	155
Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study Mark Agius, Gabriela Kłodowska-Duda, Maciej Maciejowski, Multiple Sclerosis Journal	2017	137
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial Bruce Cree, Gary Cutter, Jerry S. Wolinsky, The Lancet Neurology	2020	99
Autoantibodies in Thymoma-Associated Myasthenia Gravis With Myositis or Neuromyotonia Åse Mygland, Angela Vincent, John Newsom–Davis, Archives of Neurology	2000	95
The stress-vulnerability model how does stress impact on mental illness at the level of the brain and what are the consequences? Cindy Goh, Mark Agius PubMed	2010	87
The Psychology of Scars: A Mini-Review. Mark Agius PubMed Scar ManagementFairy TalesPsychosocial DeterminantEducationDermatology	2018	83
The staging model in schizophrenia, and its clinical implications. Mark Agius, Cindy Goh, Sophia Ulhaq, PubMed	2010	70
The use of Music Therapy in the treatment of Mental Illness and the enhancement of Societal Wellbeing. Shentong Wang, Mark Agius PubMed MusicPsychiatryMedicineMusic ProcessingSocial Sciences	2018	70
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis Robert J. Fox, Christopher S. Coffey, Merit Cudkowicz, Contemporary Clinical Trials Neurological DisorderClinical NeurologyClinical TrialsNeurological ProgressProgressive Multiple Sclerosis	2016	66

Page 1